Likely active: portfolio news Jan 2026 Verified 7 Nov 2026
AdBio partners
Paris-based life sciences venture capital firm (formerly Advent France Biotechnology) that invests in and builds early-stage European therapeutics startups, often from academic research.
- Type
- VC firm
- Location
- Paris, France
- Stages
- Pre-seed, Seed, Series A
- Sectors
- Biotech, Healthtech and life sciences
- Website
- adbio.partners
Contacts on file
For AdBio partners, the paid file holds: 3 named decision-makers with roles; firm contact email (domain checked); how to pitch (the route the firm publishes); LinkedIn page.
Get Europe Complete, $99 Free sample
One-time payment. No subscription. No account.
Notable investments
Alderaan BiotechnologyAndzonBio2Anoat TherapeuticsCalida TherapeuticsYukin Therapeutics
Sources
- adbio.partners/
- adbio.partners/team/
- adbio.partners/portfolio/
- adbio.partners/about-us/
- adbio.partners/contact/
- adbio.partners/news/
Last checked 7 Nov 2026. Is something wrong? Tell us.
Appears in 22 lists
Healthtech investors in Paris (60)Venture capital firms in France (81)Biotech investors in Europe (89)Startup investors in Paris (114)Pre-seed biotech investors (148)Series A biotech investors (153)Startup investors in France (189)Pre-seed investors in Europe (260)Healthtech investors in Europe (291)Seed biotech investors (300)Series A investors in Europe (329)Series A healthtech investors (401)Pre-seed healthtech investors (408)Venture capital firms in Europe (412)Biotech investors (484)Seed investors in Europe (543)Startup investors in Europe (725)Seed healthtech investors (800)Series A investors (864)Pre-seed investors (988)Healthtech investors (1,207)Seed investors (1,892)